SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
35.59
+0.81 (2.33%)
Dec 20, 2024, 4:00 PM EST - Market closed
SpringWorks Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 2,647 | 2,682 | 1,616 | 3,020 | 3,476 | 1,655 | |
Market Cap Growth | 64.80% | 65.95% | -46.49% | -13.11% | 109.99% | - | |
Enterprise Value | 2,155 | 2,267 | 970 | 2,541 | 3,199 | 1,311 | |
Last Close Price | 35.59 | 36.50 | 26.01 | 61.98 | 72.52 | 38.49 | |
PS Ratio | 18.88 | 492.39 | - | - | 99.31 | - | |
PB Ratio | 4.97 | 4.28 | 2.90 | 7.15 | 6.24 | 5.14 | |
P/TBV Ratio | 4.47 | 4.36 | 2.90 | 7.15 | 6.24 | 5.14 | |
EV/Sales Ratio | 15.91 | 416.18 | - | - | 91.40 | - | |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | - | |
Asset Turnover | 0.25 | 0.01 | - | - | 0.08 | - | |
Quick Ratio | 5.80 | 6.21 | 11.60 | 12.46 | 28.87 | 27.37 | |
Current Ratio | 6.16 | 6.41 | 11.75 | 12.78 | 29.15 | 27.68 | |
Return on Equity (ROE) | -59.33% | -54.90% | -56.58% | -35.51% | -10.37% | -31.89% | |
Return on Assets (ROA) | -34.28% | -31.62% | -32.40% | -21.08% | -6.36% | -19.32% | |
Return on Capital (ROIC) | -39.19% | -35.83% | -35.54% | -22.05% | -6.57% | -20.25% | |
Earnings Yield | -10.40% | -12.12% | -17.16% | -5.76% | -1.31% | -3.52% | |
FCF Yield | -7.93% | -8.58% | -10.63% | -4.30% | -0.94% | -2.91% | |
Buyback Yield / Dilution | -15.26% | -18.45% | -9.88% | -12.00% | -226.18% | -3792.75% | |
Total Shareholder Return | -15.26% | -18.45% | -9.88% | -12.00% | -226.18% | -3792.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.